Latest period
$109B
YoY change
+6.5%
5Y CAGR
+3.6%
Peak year (FY2025)
$86.7B
Latest annual
$86.7B
Total Assets history chart for Abbott Laboratories (ABT) from 2016 to 2025
Latest: $86.7B
Total Assets growth chart for Abbott Laboratories (ABT) from 2016 to 2025
Latest: +6.5%
Total Assets history table for Abbott Laboratories (ABT) from 1985 to 2025
| FY2025 | $86.7B | +6.5% | +$5.3B | ||
| FY2024 | $81.4B | +11.2% | +$8.2B | ||
| FY2023 | $73.2B | -1.6% | -$1.22B | ||
| FY2022 | $74.4B | -1.0% | -$758M | ||
| FY2021 | $75.2B | +3.6% | +$2.65B | ||
| FY2020 | $72.5B | +6.9% | +$4.66B | ||
| FY2019 | $67.9B | +1.1% | +$714M | ||
| FY2018 | $67.2B | -11.9% | -$9.08B | ||
| FY2017 | $76.3B | +38.6% | +$21.2B | ||
| FY2016 | $55B | +25.0% | +$11B | ||
| FY2015 | $44B | +0.5% | +$210M | ||
| FY2014 | $43.8B | +2.0% | +$838M | ||
| FY2013 | $43B | -36.1% | -$24.3B | ||
| FY2012 | $67.2B | +11.5% | +$6.96B | ||
| FY2011 | $60.3B | -0.5% | -$297M | ||
| FY2010 | $60.6B | +15.2% | +$7.99B | ||
| FY2009 | $52.6B | +24.0% | +$10.2B | ||
| FY2008 | $42.4B | +6.8% | +$2.71B | ||
| FY2007 | $39.7B | +9.8% | +$3.54B | ||
| FY2006 | $36.2B | +24.1% | +$7.04B | ||
| FY2005 | $29.1B | +1.3% | +$374M | ||
| FY2004 | $28.8B | +7.7% | +$2.05B | ||
| FY2003 | $26.7B | +10.1% | +$2.46B | ||
| FY2002 | $24.3B | +4.1% | +$963M | ||
| FY2001 | $23.3B | +52.4% | +$8.01B | ||
| FY2000 | $15.3B | +5.6% | +$812M | ||
| FY1999 | $14.5B | +9.5% | +$1.25B | ||
| FY1998 | $13.2B | +9.6% | +$1.16B | ||
| FY1997 | $12.1B | +8.4% | +$935M | ||
| FY1996 | $11.1B | +18.2% | +$1.71B | ||
| FY1995 | $9.41B | +10.4% | +$889M | ||
| FY1994 | $8.52B | +10.9% | +$835M | ||
| FY1993 | $7.69B | +10.8% | +$747M | ||
| FY1992 | $6.94B | +11.0% | +$686M | ||
| FY1991 | $6.26B | +12.4% | +$692M | ||
| FY1990 | $5.56B | +14.7% | +$712M | ||
| FY1989 | $4.85B | +0.5% | +$26.5M | ||
| FY1988 | $4.83B | +10.0% | +$439M | ||
| FY1987 | $4.39B | +13.5% | +$520M | ||
| FY1986 | $3.87B | +11.5% | +$397M | ||
| FY1985 | $3.47B | — | — |
- FY2025$86.7B+6.5%
- FY2024$81.4B+11.2%
- FY2023$73.2B-1.6%
- FY2022$74.4B-1.0%
- FY2021$75.2B+3.6%
- FY2020$72.5B+6.9%
- FY2019$67.9B+1.1%
- FY2018$67.2B-11.9%
- FY2017$76.3B+38.6%
- FY2016$55B+25.0%
- FY2015$44B+0.5%
- FY2014$43.8B+2.0%
- FY2013$43B-36.1%
- FY2012$67.2B+11.5%
- FY2011$60.3B-0.5%
- FY2010$60.6B+15.2%
- FY2009$52.6B+24.0%
- FY2008$42.4B+6.8%
- FY2007$39.7B+9.8%
- FY2006$36.2B+24.1%
- FY2005$29.1B+1.3%
- FY2004$28.8B+7.7%
- FY2003$26.7B+10.1%
- FY2002$24.3B+4.1%
- FY2001$23.3B+52.4%
- FY2000$15.3B+5.6%
- FY1999$14.5B+9.5%
- FY1998$13.2B+9.6%
- FY1997$12.1B+8.4%
- FY1996$11.1B+18.2%
- FY1995$9.41B+10.4%
- FY1994$8.52B+10.9%
- FY1993$7.69B+10.8%
- FY1992$6.94B+11.0%
- FY1991$6.26B+12.4%
- FY1990$5.56B+14.7%
- FY1989$4.85B+0.5%
- FY1988$4.83B+10.0%
- FY1987$4.39B+13.5%
- FY1986$3.87B+11.5%
- FY1985$3.47B—
Total Assets values are taken from Abbott Laboratories's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Assets at Abbott Laboratories (ABT)
According to Abbott Laboratories's latest reported financial statements, the company's latest reported total assets is $109B. Total assets sum everything the company reports owning at the end of each reporting period — cash, receivables, inventory, property, plant, equipment, intangibles, and other holdings — as filed on the balance sheet. Compare with total liabilities and total equity for the capital-structure picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Abbott Laboratories (ABT) most recent annual total assets stands at $86.7B (2025) – grew 6.5% year-over-year.
Abbott Laboratories total assets has grown for 2 consecutive years, with a +3.6% compound annual growth rate over 2020–2025 (5 years).
2025 marks the peak total assets at $86.7B, with the historical low of $3.47B recorded in 1985.
Abbott Laboratories Total Assets by Year
Abbott Laboratories Total Assets 2025: $86.7B
Abbott Laboratories total assets in 2025 was $86.7B, grew 6.5% from 2024. This figure represents the highest annual value in the available history.
Abbott Laboratories Total Assets 2024: $81.4B
2024's total assets for Abbott Laboratories came in at $81.4B, grew 11.2% from 2023.
Abbott Laboratories Total Assets 2023: $73.2B
Abbott Laboratories posted total assets of $73.2B in 2023, edged down 1.6% below 2022.
Abbott Laboratories Total Assets 2022: $74.4B
In 2022, Abbott Laboratories reported total assets of $74.4B, edged down 1.0% below 2021.
Abbott Laboratories Total Assets 2021: $75.2B
Abbott Laboratories total assets in 2021 was $75.2B.
See more financial history for Abbott Laboratories (ABT).
Sector peers by Total Assets
Healthcare peers of Abbott Laboratories (ABT), ranked by their latest total assets
| $310B | |
| $199B | |
| $137B | |
| $134B | |
| $114B | |
| $112B | |
| $110B | |
| $90.6B |
- $137B
- $134B
- $114B
- $112B
- $90.6B
Frequently asked questions
Test yourself on ABT
Market Cap — 10 rounds, every one of them ABT against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
Abbott Laboratories (ABT) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks1.16% TTM
- Dividend Profile2.30% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History9 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.